Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Intent to Sole Source - NeurOptics NPi-300 Pupillometry System Procurement

Active
NOI-CC-OLAO-26-008539Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institute of Health Clinical Center intends to negotiate a sole source contract with NeuroOptics for the procurement of NPi-300 pillometers, the NPi-Connect EMR interoperability package, and SmartGuard single-patient disposables. The acquisition also includes necessary device training, warranty, and service support. This procurement is being conducted on an other than full and open competition basis under the statutory authority that only one responsible source can satisfy the agency requirements. This notice is an intent to sole source and not a request for proposal. Interested parties capable of providing the required equipment and services may submit a capability statement to the designated point of contact by August 27, 2026. The government maintains full discretion in determining whether to compete the requirement based on the responses received by the deadline.

General Info

NIH intends to sole source pillometers and support services from NeuroOptics.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

339112 - Surgical and Medical Instrument ManufacturingView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
ContactsNo contacts available
OfficeBethesda, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressBethesda, MD, 20892, USA
ContactsNo contact information available

Full Description

Show more

This is a Notice of Intent, not a request for proposal.  The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: NeuroOptics.


Acquisition Description:


- NeurOptics NPi(r)-300 pillometers


- NPi-Connect EMR interoperability package


- SmartGuard(r) single-patient disposables


- Device training, warranty, and service support


The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.  All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-008539) by 12:00 PM eastern standard time on 08/27/2026 to: valerie.gregorio@nih.gov.


All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.


Similar Contracts

Same NAICS industry code

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
New
Federal
National NeuroHIV Tissue Consortium (NNTC) - Clinical Sites
Solicitation # 75N98026R00139
The National Institute of Mental Health plans to modify two existing contracts with the University of California, San Diego and Washington University to increase funding for Task 2 of the National NeuroHIV Tissue Consortium, which supports clinical research on HIV-related neurocognitive and mental health outcomes. The modification to UCSD’s contract will raise its value by $269,941 to $13,774,419, extending performance through August 22, 2027, while WASHU’s contract will increase by $543,301.63 to $8,322,165.63 through September 22, 2027. These adjustments are necessary to sustain critical participant recruitment, clinical assessments, and longitudinal follow-up essential for advancing HIV cure research, particularly through viral reservoir assays and other cure-relevant measures that leverage existing, deeply characterized cohorts. The work also includes the collection, storage, and distribution of central and peripheral nervous system tissues, cerebrospinal fluid, and associated clinical data to a national research community, aligning with the NIMH’s mission to understand how immune dysregulation and psychosocial stress impact brain health. The contracts are sole-source actions authorized under 41 U.S.C. 3304(a)(1) and the Revolutionary FAR Overhaul, as no other entities possess the established infrastructure, participant pools, and neuropsychiatric expertise required to continue this work without disruption. Classified under NAICS code 541715 with a 1,000-employee small business size standard, the effort supports a national resource established in 1998 that provides high-quality biospecimens and clinical data from both HIV-positive and HIV-negative donors. The modification ensures continuity in advancing research on HIV-associated CNS complications, aging with long-term HIV and antiretroviral therapy, and mechanisms underlying neurocognitive decline. While no competitive solicitation will be issued, interested parties may submit capability statements or objections by August 22, 2026, to the Contracting Officer at NIH, with all responses required to include active SAM registration, a Unique Entity Identifier, and Taxpayer Identification Number. The government retains full discretion to proceed non-competitively regardless of received feedback.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 days ago

DEADLINE

in 10 days
View Details
NAICS: 811210
New
Federal
Preventative Maintenance Service Contract for the Scan Module LSM 880 Microscope
Solicitation # 75N98026Q00966
The National Institutes of Health intends to award a sole-source preventative maintenance service contract to Carl Zeiss Microscopy for the Scan Module LSM 880 Microscope, serial number 2802000272, an existing government-owned instrument originally manufactured by the same vendor. The contract requires that all maintenance be performed by OEM-certified factory-trained technicians using only OEM-authorized parts, ensuring the highest level of technical compatibility and performance integrity. Due to the proprietary nature of the equipment and the specialized expertise required, Carl Zeiss Microscopy is the only vendor capable of meeting these specifications, justifying the sole-source procurement approach. The solicitation, identified by number 75N98026Q00966, was posted on August 6, 2026, with responses due by August 21, 2026, and the service contract is expected to be awarded around September 15, 2026. The contract falls under NAICS code 811210 for scientific and technical services and will be managed by the National Institutes of Health under the Department of Health and Human Services. Performance is scheduled to occur in Baltimore, Maryland, while the contracting office is located in Bethesda, Maryland. Polina Klimenkova is the point of contact for inquiries, and all necessary details are available through the provided SAM.gov link.
Electronic and Precision Equipment Repair and Maintenance

POSTED

7 days ago

DEADLINE

in 9 days
View Details
NAICS: 541715
Federal
Controlled Substances Repository & Inventory ManagementThe contract is for the development and ongoing operation of a secure, web-based inventory system designed to track controlled chemical and biological compounds in compliance with DEA regulations. The system must provide real-time monitoring of storage conditions, ensuring environmental parameters such as temperature and humidity remain within required limits to maintain the integrity and safety of regulated substances. It must support full audit trails, user authentication, access controls, and reporting capabilities to meet federal compliance standards for handling controlled materials. This subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, has a North American Industry Classification System code of 541715 and is targeted for performance in Bethesda. The solicitation was posted on July 30, 2026, with responses due by August 15, 2026. The system is expected to integrate seamlessly into existing federal research infrastructure and maintain rigorous data security protocols to protect sensitive compound information. While specific technical requirements and deliverables are not outlined here, the contract implies a high degree of regulatory precision, system reliability, and continuous compliance oversight.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

14 days ago

DEADLINE

in 2 days
View Details
NAICS: 541715
Federal
Purity Specifications, Storage and Distribution for Medications Development
Solicitation # 75N98026R00136
The National Institute on Drug Abuse under the National Institutes of Health is seeking capability statements from small businesses to serve as a centralized repository for chemical and biological compounds used in medication development. The contractor must possess in-house infrastructure to inventory, analyze, and store substances ranging from milligram to kilogram quantities, accommodating both non-GMP and GMP-grade materials sourced domestically and internationally. A critical requirement is the possession of a DEA Research Registration for Schedules II through V controlled substances, with the potential need to handle Schedule I compounds under the Controlled Substances Act of 1970. The facility must maintain rigorous purity specifications and secure distribution protocols to ensure compliance with federal regulations and the integrity of research materials. This notice is a sources sought announcement and not a solicitation for proposals or quotations; responses will not result in a contract award nor will the government compensate respondents for information provided. Interested parties must submit capability statements by August 15, 2026, to the point of contact Polina Klimenkova at polina.klimenkova@nih.gov. The North American Industry Classification System code is 541715, and performance will occur in Bethesda, Maryland. All submitted information should be clearly marked as proprietary if applicable, and no contractual obligation is implied by this announcement.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

14 days ago

DEADLINE

in 2 days
View Details